Cargando…
Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis
Current evidence about the association between pioglitazone and bladder cancer risk remains conflict. We aimed to assess the risk of bladder cancer associated with the use of pioglitazone and identify modifiers that affect the results. We systematically searched PubMed, Embase, and Cochrane Central...
Autores principales: | Tang, Huilin, Shi, Weilong, Fu, Shuangshuang, Wang, Tiansheng, Zhai, Suodi, Song, Yiqing, Han, Jiali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911601/ https://www.ncbi.nlm.nih.gov/pubmed/29476615 http://dx.doi.org/10.1002/cam4.1354 |
Ejemplares similares
-
Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
por: Jin, Haiying, et al.
Publicado: (2016) -
Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
por: Filipova, Elena, et al.
Publicado: (2017) -
Intravenous Parecoxib for Pain Relief after Orthopedic Surgery: A Systematic Review and Meta-analysis
por: Li, Xiaofei, et al.
Publicado: (2022) -
Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis
por: Yan, Huaqing, et al.
Publicado: (2018) -
Fruits, vegetables, and bladder cancer risk: a systematic review and meta-analysis
por: Vieira, Ana R, et al.
Publicado: (2015)